Heron Therapeutics reported $50.44M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
ALKERMES ALKS:US $ 263.96M 9.31M
Alnylam Pharmaceuticals ALNY:US $ 1.07B 497.67M
Amarin AMRN:US $ 240.5M 12.5M
Ani Pharmaceuticals ANIP:US $ 56.28M 7.1M
Anika Therapeutics ANIK:US $ 87.78M 3.62M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Eisai 4523:JP Y 264.53B 23.29B
Emergent Biosolutions EBS:US $ 240.9M 117.2M
Endo International Ordinary Shares ENDP:US $ 1.05B 137.68M
Esperion Therapeutics ESPR:US $ 159.4M 36.46M
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Heron Therapeutics HRTX:US $ 50.44M 1.83M
Immunogen IMGN:US $ 309.51M 64.36M
Insmed INSM:US $ 414.63M 1.44M
Jazz Pharmaceuticals JAZZ:US 482.67M 191.74M
Ligand Pharmaceuticals LGND:US $ 121.41M 116.13M
Nektar Therapeutics NKTR:US $ 105.76M 28.21M
Neurocrine Biosciences NBIX:US $ 212.2M 48.9M
Omeros OMER:US $ 145.53M 131.4M
Pacira Pharmaceuticals PCRX:US $ 109.42M 12.64M
Regeneron Pharmaceuticals REGN:US $ 3.49B 96.2M
Sangamo Biosciences SGMO:US $ 94.57M 23.14M
Surmodics SRDX:US $ 19M 1.08M
Teva Pharmaceutical Industries TEVA:US $ 2.22B 167M
Ultragenyx Pharmaceutical RARE:US $ 391.65M 231.78M
Veracyte VCYT:US $ 170.11M 16.66M
Vertex Pharmaceuticals VRTX:US $ 9.17B 469.3M